• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in whistleblower

Sun Pharma, Officials Including Dilip Shanghvi Settle Case Of Alleged Market Norms Violation With SEBI

Sebi had received two whistleblower complaints, wherein allegations were made against Sun Pharmaceutical Industries Ltd (SPIL) and its wholly-owned subsidiary Sun Pharmaceutical Laboratories Ltd (SPLL), alleging that the firms had been diverting funds through its sole distributor in India, Aditya Medisales Ltd.

Read More

Infosys Clarifies On Whistleblower Complaint Reports

All material information has been disclosed by the company as per Sebi norms and the firm's materiality policy.

Read More

Infosys Says No Prima Facie Evidence On Whistleblower Complaints

In a letter to the National Stock Exchange dated Nov. 2, the company said the anonymous complaints were still under investigation.

Read More

US SEC Probes Infosys On Whistleblower Complaints, SEBI And BSE Ask For Details

On Wednesday, BSE (earlier known as Bombay Stock Exchange) had asked Infosys to explain why it did not make a disclosure about the whistleblower complaints.

Read More

BSE Asks Infosys To Explain Its Non-Disclosure Of Whistleblower Complaint

BSE said it is observed that Infosys has not made any disclosures under Regulation 30 of SEBI (LODR) Regulations 2015.

Read More

Boardrooms In Crisis

Even with the private companies, the average retail investor and analyst knows little about what happens in these august boardrooms.

Read More